On 7 September 2021 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 4 year period of ineligibility on the Athlete K.M. Khushbu Guptah after she tested positive for the prohibited substance Mephentermine. Hereafter the Athlete appealed the Decision with the Anti-Doping Appeal Panel of India (ADAPI).
The Athlete denied the intentional use of the substance and requested for a reduced sanction. She explained that she had received and used a tablet for the treatment of her muscular pain.
INADA contended that without corroborating evidence the Athlete failed to demonstrate that the violation was not intentional while she also didn't mention this product on the Doping Control Form.
The Appeal Panel confirms that the presence of the prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.
The Appeal Panel concludes that the Athlete failed to establish that the violation was not intentional nor grounds for No Fault or Negligence.
Therefore ADAPI decides on 20 April 2022 to dismiss the Athlete's appeal and to confirm the ADDPI Decision of 7 Sepember 2021 for the imposition of a 4 year period of ineligibility on the Athlete.
